Pharmaceutical Meets Telehealth: Novo Nordisk and Hims & Hers Settle Patent Dispute with Strategic Alliance
Novo Nordisk A/S and Hims & Hers Health Inc. recently announced a resolution to a patent infringement lawsuit, accompanied by a collaborative agreement that allows Novo Nordisk to sell its GLP-1 medications through the Hims & Hers platform. This decision marks a noteworthy step in the growing intersection of traditional pharmaceuticals and telehealth platforms, as…